Zindol

Zindol is a biotechnology and nutraceutical company focused on the development and commercialization of standardized ginger-based therapeutics for supportive care in oncology. The company's lead product, Zindol, is a proprietary, standardized ginger extract specifically formulated to reduce the severity of chemotherapy-induced nausea and vomiting (CINV). Clinical research, including large-scale Phase 3 trials supported by the National Cancer Institute, has demonstrated that Zindol significantly reduces nausea when used as an adjuvant to standard antiemetic regimens. The company aims to provide evidence-based natural alternatives to improve the quality of life for cancer patients undergoing treatment.